Identity
- Trade Name
- VitreJect-DL Ophthalmic Needle FDA UDI
- Generic Name
- Hypodermic needle, single-use FDA UDI
- Device Name
- The VitreJect® LDS Safety Needles are designed to provide a means of fluid injection and aspiration. The devices are single-lumen needles intended for use with a luer-tip syringe. The Low Dead Space (LDS) needle has a decreased internal volume within the luer taper to reduce fluid volume loss. The VitreJect® LDS Safety Needle has a spring-actuated, non-removable sliding cap that protects the needle prior and during its use. They are intended for use by health care professionals for administration of drugs. Their operation is manual. The VitreJect® LDS Needles are single use only, non-toxic, non-pyrogenic, and sterilized by ethylene oxide gas. The VitreJect® LDS Safety Needles are suitable for intravitreal use. FDA UDI
- Model / Reference
- PN0625-03 FDA UDI
- Description
- The VitreJect® LDS Safety Needles are designed to provide a means of fluid injection and aspiration. The devices are single-lumen needles intended for use with a luer-tip syringe. The Low Dead Space (LDS) needle has a decreased internal volume within the luer taper to reduce fluid volume loss. The VitreJect® LDS Safety Needle has a spring-actuated, non-removable sliding cap that protects the needle prior and during its use. They are intended for use by health care professionals for administration of drugs. Their operation is manual. The VitreJect® LDS Needles are single use only, non-toxic, non-pyrogenic, and sterilized by ethylene oxide gas. The VitreJect® LDS Safety Needles are suitable for intravitreal use. FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00850040387360 FDA UDI
- 510(k) Number
- K242956 FDA UDI
- FDA Product Code
- QYM FDA UDI
- GMDN Term
- Hypodermic needle, single-use FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 880.5570 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Hypodermic needle, single-use
VitreJect-DL Ophthalmic Needle by Ocuject, LLC — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Hypodermic needle, single-use.
- Monoject — Cardinalhealth · Class II
- Pinpoint GT — Bard Access Systems, Inc. · Class II
- Safety Needle — Jiangsu Micsafe Medical Technology Co., Ltd · Class IIa
- Syringe w/Needle, Non-Toxic, 25G x 1", Luer Lock — Dynarex Corp. · Class II
- Yeso med — WUXI YUSHOU MEDICAL APPLIANCES CO., LTD. · Class II
- EasyTouch — MHC Medical Products · Class II
- STERiJECT TM — TSK LABORATORY, JAPAN · Class II
- Comfort EZ Pro — S.D.I. USA, INC. · Class II
Cleared under the same submission
K242956 also covers:
- OcuSafe Ophthalmic Needle — Ocuject, LLC
- OcuSafe Ophthalmic Needle — Ocuject, LLC
- OcuSafe Ophthalmic Needle — Ocuject, LLC
- OcuSafe Ophthalmic Needle — Ocuject, LLC
- OcuSafe-XL Ophthalmic Needle — Ocuject, LLC
- VitreJect Ophthalmic Needle — Ocuject, LLC
- VitreJect Ophthalmic Needle — Ocuject, LLC
- VitreJect Ophthalmic Needle — Ocuject, LLC
- VitreJect Ophthalmic Needle — Ocuject, LLC
- VitreJect Ophthalmic Needle — Ocuject, LLC
- VitreJect Ophthalmic Needle — Ocuject, LLC
- VitreJect-DL Ophthalmic Needle — Ocuject, LLC
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Ocuject, LLC
Sources (1)
- FDA UDI d1c10f36-23ed-4745-9e52-0164f5415ae2 35 fields · synced May 30, 2026